FREES FUND
Lei Wang is a seasoned professional with extensive experience in the pharmaceutical and consulting sectors. Currently serving as a Partner at FreeS Fund since October 2015, Lei has previously held positions as a Senior Consultant at IMS Consulting Group and as a Senior Manager at Sunovion Pharmaceuticals, where responsibilities included managing brand forecasts across various therapeutic categories and leading commercial insights for LATUDA. Additional experience includes an MBA internship at LabCorp and a role as Chief Scientific Officer at Beijing LabX. Lei holds a PhD in Physiology & Molecular Biology from the University of Notre Dame and an MBA in Healthcare Management and Finance from Boston University's Questrom School of Business.
FREES FUND
FREES FUND is a venture capital firm that provides both early and growth stage investment to technology startups in both China and the U.S.